Global Acute Ischemic Stroke Diagnosis and Treatment Market’s Future Lies in MRI, Expected to Reach US$1.9 bn by 2020 The global acute ischemic stroke diagnosis and treatment market is expected to reach US$1.869 bn before the end of 2020. It is progressing at a CAGR of 6.3% within a forecast period from 2014 to 2020. The market was valued at US$1.225 bn in 2013, according to the findings of a research report released by Transparency Market Research. The leading market intelligence provider has recently published a new report pertaining to the pharmaceutical sector, titled “Acute Ischemic Stroke Diagnosis and Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.” The market analysts have added a wide array of research points backed by expert opinions.
Acute ischemic strokes imply the loss of brain function created by the lack of blood supply to the brain. The most common cause of acute ischemic strokes is the formation of atherosclerosis plaques that narrow or block blood vessels. Another major cause is the formation of blood clots in the arteries to the brain. According to the report, the primary factor responsible for the current growth rate of the global acute ischemic stroke diagnosis and treatment market is the increasing prevalence of the disease. This market’s growth rate is further supported by the developments that modern medicine and medical devices are allowing in it. Due to the incorporation of these